These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 17699173

  • 21. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
    Maurizi N, Olivotto I, Olde Nordkamp LR, Baldini K, Fumagalli C, Brouwer TF, Knops RE, Cecchi F.
    Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
    [Abstract] [Full Text] [Related]

  • 22. Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy.
    Konstantinou DM, Efthimiadis GK, Vassilikos V, Paraskevaidis S, Pagourelias E, Maron BJ, Karvounis H.
    J Cardiovasc Med (Hagerstown); 2016 Jun; 17(6):433-9. PubMed ID: 26885981
    [Abstract] [Full Text] [Related]

  • 23. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
    Chatrath R, Porter CB, Ackerman MJ.
    Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
    [Abstract] [Full Text] [Related]

  • 24. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
    Nazer B, Dale Z, Carrassa G, Reza N, Ustunkaya T, Papoutsidakis N, Gray A, Howell SJ, Elman MR, Pieragnoli P, Ricciardi G, Jacoby D, Frankel DS, Owens A, Olivotto I, Heitner SB.
    Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
    [Abstract] [Full Text] [Related]

  • 25. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
    Magnusson P, Gadler F, Liv P, Mörner S.
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
    [Abstract] [Full Text] [Related]

  • 26. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J, Bader YH, Maron MS, Rowin EJ, Link MS.
    J Am Heart Assoc; 2016 Feb 12; 5(2):. PubMed ID: 26873684
    [Abstract] [Full Text] [Related]

  • 27. Prolongation of the QTc interval predicts appropriate implantable cardioverter-defibrillator therapies in hypertrophic cardiomyopathy.
    Gray B, Ingles J, Medi C, Semsarian C.
    JACC Heart Fail; 2013 Apr 12; 1(2):149-55. PubMed ID: 24621839
    [Abstract] [Full Text] [Related]

  • 28. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ, Spirito P.
    J Cardiovasc Electrophysiol; 2008 Oct 12; 19(10):1118-26. PubMed ID: 18384577
    [Abstract] [Full Text] [Related]

  • 29. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M.
    Am Heart J; 2007 Nov 12; 154(5):899-907. PubMed ID: 17967596
    [Abstract] [Full Text] [Related]

  • 30. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R, Sapp JL, Basta M, Doucette S, Thompson K, Gardner M, Gray C, Brownell B, Kidwai H, Cox J.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):706-13. PubMed ID: 22685111
    [Abstract] [Full Text] [Related]

  • 31. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB, Cheng KA, Gao P, Cheng ZW, Fan JB, Jiang XC, Fang Q.
    Chin Med J (Engl); 2010 Apr 05; 123(7):848-51. PubMed ID: 20497676
    [Abstract] [Full Text] [Related]

  • 32. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.
    Z Kardiol; 2000 Apr 05; 89 Suppl 3():194-205. PubMed ID: 10810803
    [Abstract] [Full Text] [Related]

  • 33. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.
    Maron BJ, Maron MS.
    Heart Rhythm; 2016 May 05; 13(5):1155-1165. PubMed ID: 26749314
    [Abstract] [Full Text] [Related]

  • 34. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C, Schwarz M, Ilic I, Laser KT, Lehmann R, Prinz EM, Bitter T, Vogt J, van Buuren F, Bogunovic N, Horstkotte D, Faber L.
    Can J Cardiol; 2013 Mar 05; 29(3):358-63. PubMed ID: 22749647
    [Abstract] [Full Text] [Related]

  • 35. Circadian rhythm of appropriate implantable cardioverter defibrillator discharges in patients with hypertrophic cardiomyopathy.
    Kiernan TJ, Weivoda PL, Somers VK, Ommen SR, Gersh BJ.
    Pacing Clin Electrophysiol; 2008 Oct 05; 31(10):1253-8. PubMed ID: 18811804
    [Abstract] [Full Text] [Related]

  • 36. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T, Obergassel L, Lieder F, Leuner C, Strunk-Mueller C, Meyer Zu Vilsendorf D, Beer G, Kuhn H.
    Pacing Clin Electrophysiol; 2005 Apr 05; 28(4):295-300. PubMed ID: 15826262
    [Abstract] [Full Text] [Related]

  • 37. Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.
    Magnusson P, Gadler F, Liv P, Mörner S.
    Pacing Clin Electrophysiol; 2016 Mar 05; 39(3):291-301. PubMed ID: 26681505
    [Abstract] [Full Text] [Related]

  • 38. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar 05; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 39. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
    Rowin EJ, Burrows A, Madias C, Estes NAM, Link MS, Maron MS, Maron BJ.
    Circ Arrhythm Electrophysiol; 2020 Oct 05; 13(10):e008123. PubMed ID: 32897759
    [Abstract] [Full Text] [Related]

  • 40. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
    Olde Nordkamp LR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB, Neuzil P, Wilde AA, Carter N, Husby M, Lambiase PD, Knops RE.
    Int J Cardiol; 2015 Sep 15; 195():126-33. PubMed ID: 26026928
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.